Cyber attacks: How prepared is pharma?

data-big

The pharmaceutical industry is a prime target for hackers. In 2015, a survey by Crown Records Management revealed that nearly two thirds of pharma firms had experienced breaches in data, and that one fourth of these same companies had been victims of hacking. [1]

The Northern Lincolnshire and Goole NHS Foundation Trust in the UK experienced a malware attack in late October of 2016, being forced to redirect trauma patients and cancel all other planned operations for the day of the attack. [2] In the USA, the Department of Health and Human Services Office for Civil Rights Breach Portal reported 320 cases of undermined health information in 2016, up by 18.5% compared to 2015. [3] A recent large-scale attack used ransomware known as WannaCry to extort money from victims in 150 different countries, affecting 47 NHS health trusts in England. [4]  The continued threat of malicious software is highlighting gaps in the healthcare industry’s cybersecurity capabilities.

Why is healthcare being targeted?

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical